{"id":2594,"date":"2021-08-03T16:18:16","date_gmt":"2021-08-03T06:18:16","guid":{"rendered":"https:\/\/orthocell.com\/us\/?p=2594"},"modified":"2021-09-16T15:08:19","modified_gmt":"2021-09-16T05:08:19","slug":"video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema","status":"publish","type":"post","link":"\/americas\/video-proactive-investors-orthocell-highlights-potential-for-celgro-in-treatment-of-lymphedema\/","title":{"rendered":"Video | Proactive Investors &#8211; Orthocell highlights potential for CelGro in treatment of lymphedema"},"content":{"rendered":"<p>Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro\u2122 with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/aNfw4pIu18U\" width=\"1280\" height=\"720\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro\u2122 with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).<\/p>\n","protected":false},"author":2,"featured_media":2622,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[3,1],"tags":[],"class_list":["post-2594","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media","category-video"],"aioseo_notices":[],"_links":{"self":[{"href":"\/americas\/wp-json\/wp\/v2\/posts\/2594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/americas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/americas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/comments?post=2594"}],"version-history":[{"count":1,"href":"\/americas\/wp-json\/wp\/v2\/posts\/2594\/revisions"}],"predecessor-version":[{"id":2595,"href":"\/americas\/wp-json\/wp\/v2\/posts\/2594\/revisions\/2595"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/media\/2622"}],"wp:attachment":[{"href":"\/americas\/wp-json\/wp\/v2\/media?parent=2594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/categories?post=2594"},{"taxonomy":"post_tag","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/tags?post=2594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}